A new study suggests that people with systemic lupus erythematosus (SLE) who have inadequate exposure to hydroxychloroquine (HCQ) may have higher estimated atherosclerotic cardiovascular (ASCVD) ...

Cynthia shares her lupus journey, from diagnosis and a major flare to finding strength, community and hope through Walk to End Lupus Now.

A lupus journey can be filled with uncertainty, grief, and loss, but there are ways to build resilience and navigate these difficult circumstances. I’ll never forget the day my best friend Srijana ...

New research is shedding light on the biological mechanisms that may help explain why systemic lupus erthyematosus (SLE) and other autoimmune diseases are more common in women. Two studies from the ...

In a new study, researchers found achieving low disease activity or remission is possible and meaningful for people with lupus nephritis, (LN, lupus-related kidney disease) once their kidneys start ...

The Lancet has published the positive full results ofUCB and Biogen’s Phase III PHOENYCS GO study of dapirolizumab pegol (DZP), an investigational, novel Fc-free CD40L inhibitor, for people with ...

Today, Merck KGaA, Darmstadt, Germany, whose U.S. healthcare arm is EMD Serono, announced that the first trial participant has been dosed in its Phase 3 ELOWEN study evaluating enpatoran, an ...

Last night at the 2026 Oscars, comedian Conan O’Brien made a joke during a skit to open the show that negatively associated his appearance with make-up to having lupus. Using lupus as a punchline, ...

The U.S. Food and Drug Administration (FDA) has granted Johnson & Johnson’s, nipocalimab, Fast Track designation as a potential treatment for adults with systemic lupus erythematosus (SLE). This ...

The Novartis research study is testing a potential new investigational treatment that is a single infusion of rapcabtagene autoleucel (also called rap-cel) for patients with active, refractory lupus ...

Safe, stable housing and reliable utilities are essential for overall well-being and financial security. If you are facing challenges with rent, shelter, heating or cooling costs or other essential ...

A new study exploring the investigational therapy, Zorpo-cel, met its primary safety and secondary efficacy endpoints in people with progressive and treatment-resistant systemic sclerosis (SSc), ...